angiotensin ii has been researched along with nilvadipine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujiwara, K; Hayashi, K; Nagahama, T; Ozawa, Y; Saruta, T; Wakino, S | 1 |
| Horii, M; Imagawa, K; Iwama, H; Kawata, H; Nakajima, T; Naya, N; Okayama, S; Saito, Y; Somekawa, S; Uemura, S | 1 |
1 trial(s) available for angiotensin ii and nilvadipine
| Article | Year |
|---|---|
Blocking T-type Ca2+ channels with efonidipine decreased plasma aldosterone concentration in healthy volunteers.
Topics: Adrenocorticotropic Hormone; Adult; Aldosterone; Angiotensin II; Calcium Channel Blockers; Calcium Channels, T-Type; Cross-Over Studies; Depression, Chemical; Dihydropyridines; Hemodynamics; Humans; Male; Neurotransmitter Agents; Nifedipine; Nitrophenols; Organophosphorus Compounds; Renin; Water-Electrolyte Balance | 2006 |
1 other study(ies) available for angiotensin ii and nilvadipine
| Article | Year |
|---|---|
Renal afferent and efferent arteriolar dilation by nilvadipine: studies in the isolated perfused hydronephrotic kidney.
Topics: Anesthesia; Angiotensin II; Animals; Antihypertensive Agents; Calcium Channel Blockers; Hydronephrosis; Male; Microcirculation; Nifedipine; Perfusion; Rats; Rats, Wistar; Renal Artery; Vasoconstriction; Vasodilation | 1999 |